Avanos Medical AVNS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | ||||||
| PM&R | -$1.8M-135% | $5.2M+160% | $2M+11.1% | $1.8M+800% | $200K-94.9% | |
| Total Specialty Nutrition Systems | $23.1M+12.7% | $20.5M-10.9% | $23M+27.8% | $18M-14.7% | $21.1M-15.6% | |
| Net Sales by Product | ||||||
| Enteral feeding | $84.6M+1.9% | $83M+0.4% | $82.7M+11.0% | $74.5M0.0% | $74.5M-0.7% | |
| Neonate solutions | $39.4M+22.7% | $32.1M+2.6% | $31.3M+11.0% | $28.2M+6.0% | $26.6M-13.9% | |
| Radiofrequency ablation | $34.5M-6.5% | $36.9M+6.6% | $34.6M-3.4% | $35.8M+12.9% | $31.7M-7.0% | |
| Surgical pain and recovery | $21.8M-11.7% | $24.7M+1.2% | $24.4M-3.2% | $25.2M+2.9% | $24.5M-8.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
